Global DNA Sequencing: Research, Applied and Clinical Markets

Global DNA Sequencing: Research, Applied and Clinical Markets

Report Scope

The report highlights the current and future market potential of DNA sequencing and provides a detailed analysis of market drivers, restraints and opportunities. The report also gives market projections for 2029 and includes a competitive environment and product analysis. The report provides market estimates and forecasts for DNA sequencing based on technology, product & service, end user, application, disease category, and region. By technology, the market is segmented into next-generation sequencing (NGS), third-generation sequencing (TGS), pyrosequencing, and Sanger sequencing. By product and service, the market is categorized into instruments and consumables or services. By end user, the market is segmented into academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, contract research organizations, and others. By application, the market is categorized as biopharma, microbiology, agriculture, or others. By disease category, the market is segmented into cancer, reproductive health, Mendelian disorders, and others. The report includes the company profiles of the key players, with detailed information about their business segments, financials, product portfolios, and recent developments.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years and for 2023 as the base year, with forecasts through 2029.

Report Includes

70 data tables and 59 additional tables

An overview of the global market for DNA sequencing technologies and their applications in research, applied and clinical segments

Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

A market forecast for the DNA sequencing industry, and a corresponding market share analysis by products and services, end-use segment, application, disease category and region

A look at the key market dynamics for DNA sequencing, and the regulatory scenario

Discussion of market opportunities for DNA sequencing, industry structure, applications and business considerations of sequencing technologies, along with the ongoing changes in the structure of the MedTech industry

Review of the leading next-generation sequencing (NGS) technologies, emerging applications, and the DNA sequencing-based diagnostics and research initiatives affecting the market

Analysis of patents related to novel sequencing technologies, as well as clinical trials

A discussion of ESG challenges and ESG practices in the industry

Insights into the major acquisitions and strategic alliances, competitive benchmarking of sequencing industry participants and their growth strategies

Market share analysis of the leading companies, as well as company profiles, including Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences (PacBio), and Oxford Nanopore Technologies Ltd.

Companies Mentioned

AGILENT TECHNOLOGIES INC.
BGI
F. HOFFMANN-LA ROCHE LTD.
GUARDANT HEALTH
ILLUMINA INC.
MYRIAD GENETICS INC.
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
THERMO FISHER SCIENTIFIC INC.